NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces that it will file a class action lawsuit on behalf of purchasers of Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) securities between March 10, 2021 and October 4, 2022, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you want to appear as lead plaintiff, you must call the court by January 9, 2023 at the latest.
Continue to read on GlobeNewswire https://www.globenewswire.com/news-release/2022/11/11/2554319/673/en/ROSEN-A-LEADING-LAW-FIRM-Encourages-Eiger-BioPharmaceuticals-Inc-Investors-With-Losses-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-EIGR.html
